Advances in CAR-T cell therapy for malignant solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in CAR-T cell therapy for malignant solid tumors

Published:2022-04-01 Issue:2 Volume:51 Page:175-184
ISSN:1008-9292
Container-title:Journal of Zhejiang University (Medical Sciences)
language:en
Short-container-title:J Zhejiang Univ (Med Sci)

Author:

LIU Jiao,TU Xiaoxuan,LIU Lulu,FANG Weijia

Publisher

China Science Publishing & Media Ltd.

Subject

General Medicine

Link

https://engine.scichina.com/doi/pdf/BA9816018C384A5CA2249B05B3BF3DF3

Reference78 articles.

1. CAO W, CHEN H D, YU Y W. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J, 2021, 134: 783-791.

2. 郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1):19-28.

3. BRAHMER J R, TYKODI S S, CHOW L Q M. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer[J]. N Engl J Med, 2012, 366: 2455-2465.

4. CURRAN K J, BRENTJENS R J. Chimeric antigen receptor T cells for cancer immunotherapy[J]. J Clin Oncol, 2015, 33: 1703-1706.

5. LI J, LI W, HUANG K. Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward[J]. J Hematol Oncol, 2018, 11:

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies;Recent Patents on Anti-Cancer Drug Discovery;2024-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP